TNF Pharmaceuticals Inc banner

TNF Pharmaceuticals Inc
NASDAQ:QCLS

Watchlist Manager
TNF Pharmaceuticals Inc Logo
TNF Pharmaceuticals Inc
NASDAQ:QCLS
Watchlist
Price: 2.35 USD -0.84%
Market Cap: $18.4m

Wall St Price Targets

QCLS Price Targets Summary
TNF Pharmaceuticals Inc

There are no price targets for QCLS.
Lowest Forecast
Price Target
Not Available
Average Forecast
Price Target
Not Available
Highest Forecast
Price Target
Not Available
TNF Pharmaceuticals Inc Competitors:
Price Targets
3227
PixArt Imaging Inc
18% Upside
IT
Gartner Inc
-1% Downside

Revenue
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-23%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-23%
Average Miss

Gross Profit
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
Gross Profit Forecast
is not available for TNF Pharmaceuticals Inc

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
49%
Average Beat
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
49%
Average Beat

Pre-Tax Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
Pre-Tax Income Forecast
is not available for TNF Pharmaceuticals Inc

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-100%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-100%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is QCLS's stock price target?
Not Available

QCLS does not have any price targets made by Wall Street professionals.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett